High-Intensity Focused Ultrasound Surgery for Tumor Ablation: A Review of Current Applications.
Alessandro De MaioGiulia AlfieriMonica MattonePejman GhanouniAlessandro NapoliPublished in: Radiology. Imaging cancer (2023)
The management of cancer with alternative approaches is a matter of clinical interest worldwide. High-intensity focused ultrasound (HIFU) surgery is a noninvasive technique performed under US or MRI guidance. The most studied therapeutic uses of HIFU involve thermal tissue ablation, demonstrating both palliative and curative potential. However, concurrent mechanical bioeffects also provide opportunities in terms of augmented drug delivery and immunosensitization. The safety and efficacy of HIFU integration with current cancer treatment strategies are being actively investigated in managing primary and secondary tumors, including cancers of the breast, prostate, pancreas, liver, kidney, and bone. Current primary HIFU indications are pain palliation, complete ablation of localized earlystage tumors, or debulking of unresectable late-stage cancers. This review presents the latest HIFU applications, from investigational to clinically approved, in the field of tumor ablation. Keywords: Ultrasound, Ultrasound-High Intensity Focused (HIFU), Interventional-MSK, Interventional-Body, Oncology, Technology Assessment, Tumor Response, MR Imaging © RSNA, 2023.
Keyphrases
- high intensity
- resistance training
- magnetic resonance imaging
- minimally invasive
- papillary thyroid
- drug delivery
- coronary artery bypass
- radiofrequency ablation
- prostate cancer
- palliative care
- squamous cell
- catheter ablation
- contrast enhanced
- chronic pain
- locally advanced
- neoadjuvant chemotherapy
- randomized controlled trial
- squamous cell carcinoma
- cancer therapy
- bone mineral density
- computed tomography
- pain management
- body composition
- neuropathic pain
- rectal cancer
- percutaneous coronary intervention
- spinal cord injury
- lymph node
- advanced cancer
- spinal cord
- climate change
- prognostic factors
- atomic force microscopy
- liver metastases
- bone loss
- clinical evaluation